400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR2000040970
正在进行
/
/
/
2020-12-16
/
/
Caregivers of palliative care patients
An Acceptance and Commitment Therapy – Caregiver Support Program (ACT-CSP) for family caregivers of patients receiving palliative care: A feasibility study
An Acceptance and Commitment Therapy – Caregiver Support Program (ACT-CSP) for family caregivers of patients receiving palliative care: A feasibility study
1) To test the feasibility, acceptability and preliminary efficacy of an acceptance and commitment therapy for supporting caregiver programme (ACT-CSP) on reduction of caregiver burden, anxiety and depressive symptoms and enhancement of caregiving self-efficacy, resilience and quality of life by ACT when compared to usual care, for caregivers of palliative care patients; 2) To explore ACTs potential impact on patients symptom burden.
随机平行对照
其它
After collecting participant's informed consent, a research assistant will randomly assign the participant to either ACT-CSP or TAU arm using the pre-prepared envelopes. Caregivers will be randomized to either the two arms by block randomization with varying block sizes.
Both the caregivers and the intervention facilitator cannot be blinded due to the intervention nature. All the outcome assessors will be blinded.
Departmental General Research Fund
/
40
/
2021-02-01
2023-01-31
/
Caregivers will be eligible if they are (1) aged >=18 years; (2) self- or patient-identified as a family caregiver of an adult patient receiving palliative care at the study site; (3) have been taking care of the patient in the past 3 months; (4) able to communicate in Cantonese at the time of recruitment;
请登录查看Caregivers will be excluded if they are (1) mentally incompetent (Mini-Mental State Examination (MMSE) < 23); (2) participating in regular psychosocial interventions.;
请登录查看香港理工大學護理學院
/
浙江道尔生物科技有限公司2026-04-16
新药创始人2026-04-16
丁香园 Insight 数据库2026-04-16
2021至2023年理赔服务2026-04-16
干细胞与外泌体2026-04-16
细胞与基因治疗领域2026-04-16
北京药研汇2026-04-16
正大天晴药业集团2026-04-16
复融生物2026-04-16
先通医药2026-04-16